Skip to main content

Sarah Dalton

Senior Director, Consumer Markets | Americas Cannabis Centre of Excellence

Ernst & Young LLP

Big picture perspective can spark even greater innovation. As Co-Lead of EY Americas Cannabis Centre of Excellence and US cannabis sector leader, Sarah works closely with senior executives to understand the landscape, and then maximize value creation through corporate strategy, innovation, M&A, and performance enhancement.

Sarah supports corporate and private equity clients in evaluating M&A opportunities; conducting sell-side and buy-side market studies; and identifying innovative new products and ingredients. She draws on years of experience working with state cannabis regulators across the United States to draft medical and adult-use rules; review dispensary license applications; conduct risk and control assessments; and evaluate investigation and audit procedures. Prior to her current focus on the cannabis industry, Sarah was a forensic accountant, assisting clients in various industries to arbitrate M&A working capital and earnout disputes; assess compliance and forensic risks; develop ethics and compliance programs; and design internal controls.

A graduate of Loyola University New Orleans, Sarah holds a Bachelor’s degree in accounting, as well as a Master’s of Business Administration. 

Product Type
On Demand

Valuation in Cannabis M&A, With Thoughts on Restructuring

Average Rating:
Mergers & Acquisitions |  Corporate Governance |  Finance |  Risk Management
Steven Hecht |  Sarah Dalton |  Sander Zagzebski
1 Hour 7 Minutes
Audio and Video
Access for 6 month(s) after purchase.
Short Description:
This panel will address strategies for handling valuation disputes and other post-closing adjustments arising from cannabis M&A, looking at before-the-fact transactional considerations and after-the-f...
$75.00 - Non Member Price

Showing 1 to 1 of 1 entries